GRI Bio, Inc.

GRI Bio, Inc. (ticker: GRI) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of GRI's SEC filings surfaces 2 active risk signals, including 2 auditor-change signals. GRI reported $0 in revenue and -$2.00M for the period ending 2022-03-31, with operating cash flow of -$3.69M. Cash and equivalents stood at $11.05M (up 236.7% year-over-year). Total assets of $11.34M exceed total liabilities of $794K. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

GRI Risk Flags

Consolidated view of every risk_flag row GRIhas surfaced across DredgeCap's extractor pipeline (auditor changes, late filings, delistings, going-concern, dilution, etc.). Each row carries a verbatim source_excerpt and links to the source SEC filing on EDGAR.

Category	Severity	Source	Excerpt	EDGAR
Auditor Change	high	10-K · Mar 28, 2024	PCAOB-tagged auditor in 10-K filed 2024-03-28 (accession 0001824293-24-000033) was 'Sadler, Gibb & Associates LLC' (PCAOB Firm ID: 3627). Prior 10-K filed 2023-02-24 (accession 0001824293-23-000016) was 'EisnerAmper LLP' (PCAOB Firm ID: 274…	view ↗
Auditor Change	medium	10-K · Jan 30, 2026	PCAOB-tagged auditor in 10-K filed 2026-01-30 (accession 0001824293-26-000033) was 'WithumSmith+Brown, PC' (PCAOB Firm ID: 100). Prior 10-K filed 2025-03-14 (accession 0001824293-25-000050) was 'Sadler, Gibb & Associates LLC' (PCAOB Firm ID…	view ↗

Related on GRI

Auditor & opinion →

Source for auditor_change + going-concern flags.

Share-count dilution →

Source for dilution + convertible-debt flags.

Risk-flag rows are produced by DredgeCap's extractor pipeline (lib/extract-auditor-changes, extract-late-filings, etc.). Each row carries a verbatim source_excerpt from the underlying SEC filing — no AI-generated language. Refresh runs daily. Not financial advice.